Search Within

Chaitanya Divgi

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (58)
  2. Meeting Abstract (39)
  3. Conference Paper (5)
  4. Book Section (3)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (105)
  2. Sloan Kettering Institute Faculty (105)
  3. GSK Faculty (104)
  4. Molecular Imaging and Therapy Service (103)
  5. Radiology, Department of (103)
  6. Department of Medicine (55)

More Groups

People
  1. Steven Larson (103)
  2. Ronald Finn (51)
  3. Andrew Scott (40)
  4. Lloyd Old (32)
  5. George Sgouros (28)
  6. David Scheinberg (24)

More People

Years
  1. 2012 (1)
  2. 2011 (2)
  3. 2010 (1)
  4. 2008 (1)
  5. 2007 (3)
  6. 2006 (1)

More Years

Publications
  1. Journal of Nuclear Medicine (36)
  2. Journal of Clinical Oncology (9)
  3. Clinical Cancer Research (8)
  4. Nuclear Medicine and Biology (6)
  5. Blood (5)
  6. European Journal of Nuclear Medicine (4)

More Publications

Publishers
  1. Society of Nuclear Medicine (36)
  2. American Association for Cancer Research (12)
  3. American Society of Clinical Oncology (9)
  4. Elsevier Science Inc. (6)
  5. American Society of Hematology (5)
  6. Springer Verlag (4)

More Publishers

Results (105)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Monoclonal antibody-based therapy for renal cell carcinoma
    Journal Article

    Oosterwijk, E.; Divgi, C. R.; Brouwers, A.; Boerman, O. C.; Larson, S. M.; Mulders, P.; Old, L. J.
    Urologic Clinics of North America (2003)

    Fulltext@MSK | Save
  • Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: Assessment of tumor dose-response
    Journal Article

    Sgouros, G.; Squeri, S.; Ballangrud, A. M.; Kolbert, K. S.; Teitcher, J. B.; Panageas, K. S.; Finn, R. D.; Divgi, C. R.; Larson, S. M.; Zelenetz, A. D.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer
    Journal Article

    Scott, A. M.; Wiseman, G.; Welt, S.; Adjei, A.; Lee, F. T.; Hopkins, W.; Divgi, C. R.; Hanson, L. H.; Mitchell, P.; Gansen, D. N.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias
    Journal Article

    Burke, J. M. ; Caron, P. C.; Papadopoulos, E. B.; Divgi, C. R.; Sgouros, G.; Panageas, K. S.; Finn, R. D.; Larson, S. M.; O'Reilly, R. J.; Scheinberg, D. A.; more...
    Bone Marrow Transplantation (2003)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with Bismuth-213-labeled anti-CD33 monoclonal antibody HuM195 in acute myeloid leukemia (AML)
    Meeting Abstract

    Burke, J. M.; Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Sgouros, G.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Blood (2002)

    Fulltext@MSK | Save
  • A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation
    Journal Article

    Robbins, R. J.; Larson, S. M.; Sinha, N.; Shaha, A.; Divgi, C.; Pentlow, K. S.; Ghossein, R.; Tuttle, R. M.
    Journal of Nuclear Medicine (2002)

    Fulltext@MSK | Save
  • Targeted α particle immunotherapy for myeloid leukemia
    Journal Article

    Jurcic, J. G.; Larson, S. M.; Sgouros, G.; McDevitt, M. R.; Finn, R. D.; Divgi, C. R.; Ballangrud, A. M.; Hamacher, K. A.; Ma, D.; Humm, J. L.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Renal carcinoma: Monoclonal antibody therapy
    Book Section

    Divgi, C. R.; Oosterwijk, E.; Bander, N. H.; Welt, S.; Larson, S. M.; Old, L.
    In Khalkhali, I.; Maublant, J. C.; Goldsmith, S. J. (Eds.) Nuclear Oncology: Diagnosis and Therapy (2001)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of BIBH-1 in patients with advanced or metastatic fibroblast activation protein positive cancer
    Meeting Abstract

    Scott, A. M.; Wiseman, G.; Welt, S.; Lee, F. T.; Hopkins, W.; Mitchell, P.; Adjei, A.; Divgi, C. R.; Larson, S. M.; Hoffman, E. W.; more...
    Journal of Nuclear Medicine (2001)

    Fulltext@MSK | Save
  • Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients
    Journal Article

    Tanswell, P.; Garin-Chesa, P.; Rettig, W. J.; Welt, S.; Divgi, C. R.; Casper, E. S.; Finn, R. D.; Larson, S. M.; Old, L. J.; Scott, A. M.
    British Journal of Clinical Pharmacology (2001)

    Fulltext@MSK | Save